Protez Pharmaceuticals is founded in 2003. The company operates in the Manufacturing, Pharmaceuticals sector.
Protez Pharmaceuticals specializes in Antibiotic development, Drug-resistant infection treatment, Life-threatening infection treatment, and offers services including Antibiotics, Protez (antibiotic), and PZ-601 (carbapenem antibiotic).
Total Rounds
US$ 15M
Last Round
US$ 15M
Rounds
1
Investors
Birchmere Ventures, BioAdvance, Other investors